Exact Mass: 578.3679

Exact Mass Matches: 578.3679

Found 59 metabolites which its exact mass value is equals to given mass value 578.3679, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Prednisolone 21-all-cis-farnesylate

Prednisolone 21-all-cis-farnesylate

C36H50O6 (578.3607)


   

Anhydroamarouciaxanthin B

(4Z)-4-[(3Z,5E,7Z,9Z,11Z,13E,15Z)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)


Anhydroamarouciaxanthin B is found in blue mussel. Anhydroamarouciaxanthin B is a constituent of Mytilus edulis (blue mussel). Constituent of Mytilus edulis (blue mussel). Anhydroamarouciaxanthin B is found in blue mussel and mollusks.

   

Chenodeoxycholyltryptophan

2-(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-(1H-indol-3-yl)propanoic acid

C35H50N2O5 (578.372)


Chenodeoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyltryptophan consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Deoxycholyltryptophan

2-(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-(1H-indol-3-yl)propanoic acid

C35H50N2O5 (578.372)


Deoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyltryptophan consists of the bile acid deoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Phoeniconone

3-Hydroxy-2,3-didehydro-beta,beta-carotene-4,4-dione

C40H50O3 (578.376)


   
   

Lanceolitol A5

Lanceolitol A5

C29H54O11 (578.3666)


   

Lanceolitol A6

Lanceolitol A6

C29H54O11 (578.3666)


   

4-Ketoalloxanthin

4-Ketoalloxanthin

C40H50O3 (578.376)


   

(+)-buxalongifolamidine|Buxalongifolamidine

(+)-buxalongifolamidine|Buxalongifolamidine

C35H50N2O5 (578.372)


   

nostoginin BN578

nostoginin BN578

C30H50N4O7 (578.3679)


   

3,4,4-Trioxo-beta-carotin

3,4,4-Trioxo-beta-carotin

C40H50O3 (578.376)


   

(+)-buxoxybenzamine|(-)-buxoxybenzamine

(+)-buxoxybenzamine|(-)-buxoxybenzamine

C35H50N2O5 (578.372)


   

buxafuranamide

buxafuranamide

C35H50N2O5 (578.372)


   

putative tryptophane conjugated chenodeoxycholic acid

putative tryptophane conjugated chenodeoxycholic acid

C35H50N2O5 (578.372)


   

putative tryptophane conjugated chenodeoxycholic acid (clustered spectrum)

putative tryptophane conjugated chenodeoxycholic acid (clustered spectrum)

C35H50N2O5 (578.372)


   

Tryptophane chenodeoxycholic acid

Tryptophane chenodeoxycholic acid

C35H50N2O5 (578.372)


   

Anhydroamarouciaxanthin B

(4Z)-4-[(3Z,5E,7Z,9Z,11Z,13E,15Z)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)


   

Gelliodenone

3-Hydroxy-3,4-didehydro-16-methyl-17-nor-beta,psi-caroten-4,16-dione

C40H50O3 (578.376)


   

Hydroxyclathriaxanthin

3,16-Dihydroxy-beta,chi-caroten-4-one

C40H50O3 (578.376)


   

Didehydrotrikentriorhodin

3,8-Dihydroxy-7,8-didehydro-kappa,chi-caroten-6-one

C40H50O3 (578.376)


   

Prednisolone Farnesylate

Prednisolone Farnesylate

C36H50O6 (578.3607)


   

buxalongifolamidine

buxalongifolamidine

C35H50N2O5 (578.372)


A natural product found in Buxus natalensis and Buxus longifolia.

   

PA O-18:0/8:2;O2

PA O-18:0/8:2;O2

C29H55O9P (578.3584)


   
   

PA P-18:0/8:1;O2

PA P-18:0/8:1;O2

C29H55O9P (578.3584)


   

PA 18:0/8:1;O

PA 18:0/8:1;O

C29H55O9P (578.3584)


   

PA 22:0/4:1;O

PA 22:0/4:1;O

C29H55O9P (578.3584)


   
   
   
   
   
   
   
   

(1s,2s,3s,4r,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl (9s)-9-methylheptadecanoate

(1s,2s,3s,4r,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl (9s)-9-methylheptadecanoate

C29H54O11 (578.3666)


   

(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-3-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-3-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

C36H50O6 (578.3607)


   

(1r,2s,3s,4r,5s,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl 16-methylheptadecanoate

(1r,2s,3s,4r,5s,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl 16-methylheptadecanoate

C29H54O11 (578.3666)


   

n-[(1r,5r,6r,8r,9s,11s,12s,15s,16r,18s)-9-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethyl-19-oxapentacyclo[9.8.0.0¹,¹⁸.0³,⁸.0¹²,¹⁶]nonadec-3-en-6-yl]benzenecarboximidic acid

n-[(1r,5r,6r,8r,9s,11s,12s,15s,16r,18s)-9-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethyl-19-oxapentacyclo[9.8.0.0¹,¹⁸.0³,⁸.0¹²,¹⁶]nonadec-3-en-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

6-hydroxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e,19e,21e,23e)-3,7,12,16,20-pentamethyl-25-oxohexacosa-1,3,5,7,9,11,13,15,17,19,21,23-dodecaen-1-yl]cyclohex-2-en-1-one

6-hydroxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e,19e,21e,23e)-3,7,12,16,20-pentamethyl-25-oxohexacosa-1,3,5,7,9,11,13,15,17,19,21,23-dodecaen-1-yl]cyclohex-2-en-1-one

C40H50O3 (578.376)


   

2-{[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-n-methylpropanamido)-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

2-{[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-n-methylpropanamido)-1-hydroxy-4-methylpentylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)


   

2-(but-2-en-2-yl)-6-hydroxy-1a,6-dimethyl-3-[4-(2,2,5-trimethyl-1,3-dioxan-4-yl)penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

2-(but-2-en-2-yl)-6-hydroxy-1a,6-dimethyl-3-[4-(2,2,5-trimethyl-1,3-dioxan-4-yl)penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate

C36H50O6 (578.3607)


   

3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

C40H50O3 (578.376)


   

n-[(3s,6s,7s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

n-[(3s,6s,7s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

6-hydroxy-3-[(3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

6-hydroxy-3-[(3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)


   

n-[(1s,3r,4s,6r,7s,8r,13r,16s,17s,20r)-6-(acetyloxy)-7-[(1r)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icos-10-en-16-yl]benzenecarboximidic acid

n-[(1s,3r,4s,6r,7s,8r,13r,16s,17s,20r)-6-(acetyloxy)-7-[(1r)-1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icos-10-en-16-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

(1s,2r,5r,7r,10s,14r,15r,16r,20r,25s,28r)-7,14,28-trihydroxy-6,6,10,14,21,21,25,28-octamethylheptacyclo[14.10.2.0²,¹¹.0²,¹⁵.0⁵,¹⁰.0¹⁷,²⁶.0²⁰,²⁵]octacosa-11,17(26)-diene-13,22,27-trione

(1s,2r,5r,7r,10s,14r,15r,16r,20r,25s,28r)-7,14,28-trihydroxy-6,6,10,14,21,21,25,28-octamethylheptacyclo[14.10.2.0²,¹¹.0²,¹⁵.0⁵,¹⁰.0¹⁷,²⁶.0²⁰,²⁵]octacosa-11,17(26)-diene-13,22,27-trione

C36H50O6 (578.3607)


   

2-(2-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-3-(4-hydroxyphenyl)-n-methylpropanamido)-4-methylpentanoic acid

2-(2-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-3-(4-hydroxyphenyl)-n-methylpropanamido)-4-methylpentanoic acid

C30H50N4O7 (578.3679)


   

n-[(3r,6s,7s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

n-[(3r,6s,7s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-3-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),4-dien-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

(4z)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

(4z)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)


   

n-[6-(acetyloxy)-7-[1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icos-10-en-16-yl]benzenecarboximidic acid

n-[6-(acetyloxy)-7-[1-(dimethylamino)ethyl]-13-hydroxy-4,8,17-trimethyl-19-oxapentacyclo[11.6.1.0³,¹¹.0⁴,⁸.0¹⁷,²⁰]icos-10-en-16-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

4-[(3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

4-[(3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-yn-1-ylidene]-3,5,5-trimethylcyclohex-2-en-1-one

C40H50O3 (578.376)


   

(2r)-2-[(2r,3r)-2-[(2r)-2-{[(2r,3r)-3-amino-1,2-dihydroxyoctylidene]amino}-n,3-dimethylbutanamido]-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

(2r)-2-[(2r,3r)-2-[(2r)-2-{[(2r,3r)-3-amino-1,2-dihydroxyoctylidene]amino}-n,3-dimethylbutanamido]-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)


   

6-hydroxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohexa-2,5-dien-1-one

6-hydroxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohexa-2,5-dien-1-one

C40H50O3 (578.376)


   

n-[9-(acetyloxy)-15-[1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethyl-19-oxapentacyclo[9.8.0.0¹,¹⁸.0³,⁸.0¹²,¹⁶]nonadec-3-en-6-yl]benzenecarboximidic acid

n-[9-(acetyloxy)-15-[1-(dimethylamino)ethyl]-5-hydroxy-7,7,12,16-tetramethyl-19-oxapentacyclo[9.8.0.0¹,¹⁸.0³,⁸.0¹²,¹⁶]nonadec-3-en-6-yl]benzenecarboximidic acid

C35H50N2O5 (578.372)


   

(2s)-2-[(2s,3s)-2-[(2s)-2-{[(2s,3s)-3-amino-1,2-dihydroxyoctylidene]amino}-n,3-dimethylbutanamido]-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-[(2s,3s)-2-[(2s)-2-{[(2s,3s)-3-amino-1,2-dihydroxyoctylidene]amino}-n,3-dimethylbutanamido]-n,3-dimethylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)


   

3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-3-ene-1,2-dione

C40H50O3 (578.376)


   

2-(2-{2-[(3-amino-1,2-dihydroxyoctylidene)amino]-n,3-dimethylbutanamido}-n,3-dimethylpentanamido)-3-(4-hydroxyphenyl)propanoic acid

2-(2-{2-[(3-amino-1,2-dihydroxyoctylidene)amino]-n,3-dimethylbutanamido}-n,3-dimethylpentanamido)-3-(4-hydroxyphenyl)propanoic acid

C30H50N4O7 (578.3679)